Distribuzione geografica
Continente #
NA - Nord America 7922
EU - Europa 3709
AS - Asia 709
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
AF - Africa 5
Totale 12381
Nazione #
US - Stati Uniti d'America 7766
IT - Italia 999
DE - Germania 970
SE - Svezia 592
CN - Cina 528
UA - Ucraina 226
AT - Austria 224
GB - Regno Unito 202
CA - Canada 154
IE - Irlanda 98
VN - Vietnam 86
DK - Danimarca 82
BE - Belgio 81
FR - Francia 54
FI - Finlandia 49
RU - Federazione Russa 39
IN - India 36
TR - Turchia 21
NL - Olanda 20
PL - Polonia 19
ES - Italia 14
RO - Romania 14
BR - Brasile 10
EU - Europa 10
IR - Iran 10
KR - Corea 9
AU - Australia 6
CZ - Repubblica Ceca 6
BG - Bulgaria 5
CH - Svizzera 4
CL - Cile 4
GR - Grecia 4
PH - Filippine 4
AR - Argentina 3
NO - Norvegia 3
SA - Arabia Saudita 3
SG - Singapore 3
HR - Croazia 2
IL - Israele 2
JP - Giappone 2
LU - Lussemburgo 2
MA - Marocco 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BT - Bhutan 1
EC - Ecuador 1
EG - Egitto 1
KZ - Kazakistan 1
MU - Mauritius 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 12381
Città #
Ann Arbor 2127
Fairfield 773
Frankfurt am Main 739
Chandler 722
Woodbridge 626
Wilmington 530
Houston 506
Milan 446
Dearborn 358
Ashburn 311
Seattle 305
Cambridge 244
Jacksonville 233
Vienna 222
Princeton 175
Nanjing 134
Dublin 98
Brussels 78
Lawrence 63
Altamura 62
Fremont 59
Nanchang 56
Beijing 51
Dong Ket 48
Lachine 40
San Diego 39
Montréal 38
Guangzhou 37
Ottawa 35
Shenyang 28
Toronto 27
Andover 25
Hebei 23
Lissone 23
Zhengzhou 20
Falls Church 19
Kunming 19
Tianjin 19
Jiaxing 18
Jinan 18
Changsha 16
Chicago 16
Norwalk 16
Ningbo 15
Pavia 15
Boardman 14
Brescia 14
Edmonton 14
Shanghai 14
Kiev 13
Ripalta Cremasca 13
London 12
Los Angeles 9
Mountain View 9
Philadelphia 9
Taizhou 9
Huizen 8
Napoli 8
Bergamo 7
Cinisello Balsamo 7
Nürnberg 7
Rome 7
Sacramento 7
Verona 7
Atlanta 6
Hanover 6
Kraków 6
Legnano 6
Lodi 6
Redmond 6
San Mateo 6
Segrate 6
Augusta 5
Birmingham 5
Cardano al Campo 5
Como 5
Daejeon 5
Hefei 5
Helsinki 5
Lanzhou 5
Piemonte 5
Plovdiv 5
San Giuliano Milanese 5
Brno 4
Cagliari 4
Catanzaro 4
Dallas 4
Edinburgh 4
Genova 4
Haikou 4
Hangzhou 4
Kocaeli 4
Leawood 4
Mersin 4
Muggiò 4
Nova Milanese 4
Padova 4
Phoenix 4
San Francisco 4
Vigevano 4
Totale 9831
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 388
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 339
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 314
Differential protein profiling of renal cell carcinoma urinary exosomes 297
Urinary exosomes and diabetic nephropathy: a proteomic approach 269
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 269
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 241
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 240
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 235
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 232
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 230
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 223
The proteomic landscape of renal tumors 219
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 214
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 213
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 212
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 204
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 201
Robust conclusions in mass spectrometry analysis 197
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 197
Mutual Information Optimization for Mass Spectra Data Alignment 197
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 194
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 193
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 192
The putative role of MALDI-MSI in the study of Membranous Nephropathy 188
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 185
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 184
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 180
Tumor size, stage and grade alterations of urinary peptidome in RCC 177
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 174
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 169
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 167
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 164
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 161
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 159
Proteome analysis in thyroid pathology 157
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 156
Analysis of correlation structures in renal cell carcinoma patient data 155
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 153
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 152
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 149
Imaging mass spectrometry: a new tool for kidney disease investigations 147
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 145
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 140
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 138
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 136
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 132
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 132
Intraluminal proteome and peptidome of human urinary extracellular vesicles 129
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 128
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 127
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 126
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 123
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 123
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 121
Proteomics imaging and the kidney 116
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 115
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 109
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 109
A molecular imaging approach to individuate tumour infiltrating lymphocytes 109
AQP1 expression analysis in human diseases: Implications for proteomic characterization 107
Immunoreattività e carcinoma renale 101
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 101
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 98
Characterization of distinguishing regions for Renal Cell Carcinoma discrimination 95
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 94
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 89
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 87
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 86
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 85
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 81
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 74
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 74
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 68
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 65
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 64
Method for the in vitro diagnosis of thyroid diseases 64
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 60
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 56
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 56
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 56
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 51
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 47
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 46
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 45
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 42
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 41
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 41
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 38
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 36
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 34
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 30
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects 29
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 26
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 13
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 10
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 10
Totale 13145
Categoria #
all - tutte 22181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22181

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201880 0000 00 00 003149
2018/20191421 49346318 65101 11566 102165285358
2019/20202884 304190182226 250349 434209 26720219576
2020/20212733 122148294286 220225 329292 205224154234
2021/20221539 145146134196 79127 5496 60123149230
2022/20233025 299818282322 148416 96241 219801040
Totale 13145